1. Tao W, Brunston RL Jr, Bidani A, Pirtle P, Dy J, Cardenas VJ Jr, et al. Significant reduction in minute ventilation and peak inspiratory pressures with arteriovenous CO2 removal during severe respiratory failure. Crit Care Med. 1997; 25:689–695.
2. Liebold A, Reng CM, Philipp A, Pfeifer M, Birnbaum DE. Pumpless extracorporeal lung assist: experience with the first 20 cases. Eur J Cardiothorac Surg. 2000; 17:608–613.
3. Bein T, Weber F, Philipp A, Prasser C, Pfeifer M, Schmid FX, et al. A new pumpless extracorporeal interventional lung assist in critical hypoxemia/hypercapnia. Crit Care Med. 2006; 34:1372–1377.
4. Zick G, Frerichs I, Schadler D, Schmitz G, Pulletz S, Cavus E, et al. Oxygenation effect of interventional lung assist in a lavage model of acute lung injury: a prospective experimental study. Crit Care. 2006; 10:R56.
5. Zimmermann M, Bein T, Arlt M, Philipp A, Rupprecht L, Mueller T, et al. Pumpless extracorporeal interventional lung assist in patients with acute respiratory distress syndrome: a prospective pilot study. Crit Care. 2009; 13:R10.
6. Jayroe JB, Wang D, Deyo DJ, Alpard SK, Bidani A, Zwischenberger JB. The effect of augmented hemodynamics on blood flow during arteriovenous carbon dioxide removal. ASAIO J. 2003; 49:30–34.
7. Cho WH, Lee K, Huh JW, Lim CM, Koh Y, Hong SB. Physiologic effect and safety of the pumpless extracorporeal interventional lung assist system in patients with acute respiratory failure: a pilot study. Artif Organs. 2012; 36:434–438.
8. Bein T, Zimmermann M, Philipp A, Ramming M, Sinner B, Schmid C, et al. Addition of acetylsalicylic acid to heparin for anticoagulation management during pumpless extracorporeal lung assist. ASAIO J. 2011; 57:164–168.
9. Villaneuva GB, Danishefsky I. Evidence for a heparin-induced conformational change on antithrombin III. Biochem Biophys Res Commun. 1977; 74:803–809.
10. Oliver WC. Anticoagulation and coagulation management for ECMO. Semin Cardiothorac Vasc Anesth. 2009; 13:154–175.